Video Experimental Relacionado
Updated: Mar 29, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.5K
Demencia frontotemporal
Jee Bang1, Salvatore Spina1, Bruce L Miller1
1Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
Lancet (London, England)
|November 24, 2015
Resumen
La demencia frontotemporal (FTD) es un grupo de enfermedades neurodegenerativas que afectan el comportamiento, la función ejecutiva o el lenguaje, comunes en personas menores de 65 años. Los avances en el diagnóstico ahora distinguen mejor a FTD de los trastornos psiquiátricos, allanando el camino para terapias específicas.
Área de la Ciencia:
- Neurología
- La neurociencia
- La genética
Sus antecedentes:
- La demencia frontotemporal (FTD) es un síndrome clínico caracterizado por déficits conductuales, ejecutivos o de lenguaje progresivos.
- Es una causa común de demencia en personas menores de 65 años.
- Los síntomas conductuales de FTD pueden imitar los trastornos psiquiátricos, complicando el diagnóstico.
Objetivo del estudio:
- Proporcionar una visión general de la demencia frontotemporal (FTD).
- Resaltar los desafíos de diagnóstico y los avances recientes en la diferenciación de las enfermedades de origen sexual de las psiquiátricas.
- Discutir las implicaciones de la comprensión de la base molecular de FTD para futuras terapias.
Principales métodos:
- Revisión de las características clínicas, por imágenes y moleculares de la FTD.
- Análisis de los hallazgos neuropatológicos en FTD, centrado en la degeneración de la corteza frontal y temporal.
- Examen del papel de la genética en la etiología de FTD.
Principales resultados:
- La FTD abarca diversas entidades neuropatológicas que causan degeneración selectiva de la corteza frontal y temporal.
- Los factores genéticos son factores de riesgo significativos para el desarrollo de FTD.
- La precisión diagnóstica mejorada permite una mejor diferenciación de los trastornos psiquiátricos.
Conclusiones:
- Los avances en la caracterización clínica, por imágenes y molecular mejoran la precisión del diagnóstico de FTD.
- La comprensión de los fundamentos moleculares de FTD es crucial para desarrollar estrategias terapéuticas específicas.
- El diagnóstico preciso es clave para diferenciar la FTD de las afecciones psiquiátricas e iniciar un tratamiento adecuado.
Videos de Conceptos Relacionados
01:30Dementia
702
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
702
01:21Association Areas of the Cortex
10.5K
Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
10.5K
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:24Prosopagnosia
1.1K
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
1.1K
01:14Role of Cerebellum and Prefrontal Cortex in Memory
1.4K
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
1.4K